These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16849323)

  • 1. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection.
    Dorfman T; Moore MJ; Guth AC; Choe H; Farzan M
    J Biol Chem; 2006 Sep; 281(39):28529-35. PubMed ID: 16849323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
    Choe H; Li W; Wright PL; Vasilieva N; Venturi M; Huang CC; Grundner C; Dorfman T; Zwick MB; Wang L; Rosenberg ES; Kwong PD; Burton DR; Robinson JE; Sodroski JG; Farzan M
    Cell; 2003 Jul; 114(2):161-70. PubMed ID: 12887918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
    J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.
    Huang CC; Lam SN; Acharya P; Tang M; Xiang SH; Hussan SS; Stanfield RL; Robinson J; Sodroski J; Wilson IA; Wyatt R; Bewley CA; Kwong PD
    Science; 2007 Sep; 317(5846):1930-4. PubMed ID: 17901336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
    Brower ET; Schön A; Klein JC; Freire E
    Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
    Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
    Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
    Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
    Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
    EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
    Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
    J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 mimicry by sulfated human anti-HIV-1 antibodies.
    Lin G; Hoxie JA
    Cell; 2003 Jul; 114(2):147-8. PubMed ID: 12887913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
    Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
    J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region.
    Farzan M; Chung S; Li W; Vasilieva N; Wright PL; Schnitzler CE; Marchione RJ; Gerard C; Gerard NP; Sodroski J; Choe H
    J Biol Chem; 2002 Oct; 277(43):40397-402. PubMed ID: 12183462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation.
    Dettin M; Zanchetta M; Pasquato A; Borrello M; Piatier-Tonneau D; Di Bello C; De Rossi A
    Biochem Biophys Res Commun; 2003 Aug; 307(3):640-6. PubMed ID: 12893271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.
    de Parseval A; Bobardt MD; Chatterji A; Chatterji U; Elder JH; David G; Zolla-Pazner S; Farzan M; Lee TH; Gallay PA
    J Biol Chem; 2005 Nov; 280(47):39493-504. PubMed ID: 16157597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.
    Platt EJ; Gomes MM; Kabat D
    J Virol; 2014 Apr; 88(8):4304-18. PubMed ID: 24478426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
    Platt EJ; Shea DM; Rose PP; Kabat D
    J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein.
    Kwong JA; Dorfman T; Quinlan BD; Chiang JJ; Ahmed AA; Choe H; Farzan M
    J Virol; 2011 Aug; 85(15):7563-71. PubMed ID: 21613393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.